SEC Form 4 · accession 0001209191-18-019762
Corbus Pharmaceuticals Holdings, Inc. · CRBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barbara White
Officer — Chief Medical Officer
Period of report
Mar 14, 2018
Accepted (ET)
Mar 15, 2018 · 10:18 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001595097
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 14, 2018 | P | 2,885 | $6.89 | A | 176,935 | D |
Table II — derivative securities
No Table II lines on this filing.